Company Data
Janux Therapeutics Inc.
Ticker
JANX
Current Price
$26.1 -1.55%
Market Cap
$1.6B
Price Target
Refer to Report
Volume
700.0K
52wk Range
$21.73 - $71.71
Overview
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.